Gleevec
imatinib mesylate
- Strength
- 400 mg/1
- Form
- Tablet
- Class
- Kinase Inhibitor
Novartis Pharmaceuticals Corporation
Listed by Apotex Corp
| Dosage form | Tablet, Film Coated |
|---|---|
| Route | Oral |
| Drug class | Kinase Inhibitor |
| Approval route | ANDA — approved generic |
| NDC code | 60505-2901 |
| FDA application | ANDA079179 |
| RxNorm concept | 403878 |
| Package sizes listed | 5 |
| Marketed since | August 2016 |
Same active ingredient, different manufacturer, strength or form. Products matching on both ingredient and strength are usually interchangeable — but confirm before switching, especially with modified-release forms.
imatinib mesylate
Novartis Pharmaceuticals Corporation
imatinib mesylate
Novartis Pharmaceuticals Corporation
imatinib mesylate
Novartis Pharmaceuticals Corporation
Dr.Reddy's Laboratories Inc
Dr.Reddy's Laboratories Inc
Upsher-Smith Laboratories, LLC
Teva Pharmaceuticals USA, Inc.
imatinib
Golden State Medical Supply, Inc.
Information only, not medical advice. Nothing on this page indicates that a medication is safe or suitable for you. Speak to a prescriber or pharmacist before starting, stopping or switching any medicine.
Please don't share card details in chat.